MORENO VALLEY – Even with decreasing cases and hospitalizations, those with high-risk conditions who have tested positive for COVID-19 were encouraged to get monoclonal antibody treatment at Riverside University Health System – Medical Center.In January, the U.S. Food and Drug Administration limited the use of certain monoclonal antibody therapies that were ineffective against the omicron variant. In response, RUHS – Medical Center is administering sotrovimab, an IV infusion shown to be effective against omicron and other variants.Dr. Michael Mesisca, RUHS – Medical Center’s medical director for emergency medicine, said that monoclonal antibody treatment is one of many available tools that are key to living with COVID-19.“As we come to terms with COVID-19 as an end
